Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMRN Immuron Ltd

休市中 12-19 16:00:00 EST

0.9360

-0.0080

-0.85%

盘后0.9401

+0.0041+0.44%

19:42 EST

最高0.9440	最低0.9200	成交量3.59万
今开0.9390	昨收0.9440	日振幅2.54%
总市值756.57万	流通市值747.23万	总股本808.30万
成交额3.37万	换手率0.45%	流通股本798.32万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMRN","market":"US","secType":"STK","nameCN":"Immuron Ltd","latestPrice":0.936,"timestamp":1766178000000,"preClose":0.944,"halted":0,"volume":35934,"hourTrading":{"tag":"盘后","latestPrice":0.9401,"preClose":0.936,"latestTime":"19:42 EST","volume":4920,"amount":4594.7085,"timestamp":1766191355966},"delay":0,"floatShares":7983200,"shares":8083000,"eps":-0.592303,"marketStatus":"休市中","change":-0.008,"latestTime":"12-19 16:00:00 EST","open":0.939,"high":0.944,"low":0.92,"amount":33666.01696584,"amplitude":0.025424,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.592303,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":1,"adrRate":40,"exchange":"NASDAQ","adjPreClose":0.944,"preHourTrading":{"tag":"盘前","latestPrice":0.9395,"preClose":0.944,"latestTime":"08:01 EST","volume":359,"amount":337.10288834,"timestamp":1766149280452},"postHourTrading":{"tag":"盘后","latestPrice":0.9401,"preClose":0.936,"latestTime":"19:42 EST","volume":4920,"amount":4594.7085,"timestamp":1766191355966},"volumeRatio":0.5886149349387347},"requestUrl":"/m/hq/s/IMRN","defaultTab":"news","newsList":[{"id":"2586254479","title":"Immuron Limited盘中异动 大幅拉升5.17%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586254479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586254479?lang=zh_cn&edition=full","pubTime":"2025-11-26 04:13","pubTimestamp":1764101597,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日04时13分，Immuron Limited股票出现波动，股价大幅上涨5.17%。截至发稿，该股报1.76美元/股，成交量2.055万股，换手率0.30%，振幅8.14%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.74%。Immuron Limited公司简介：Immuron Ltd 是一家商业化和临床阶段的生物制药公司，拥有专有技术平台，专注于多克隆抗体，以解决尚未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126041317a7114020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126041317a7114020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2575467637","title":"Immuron Limited盘中异动 急速上涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575467637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575467637?lang=zh_cn&edition=full","pubTime":"2025-10-16 00:47","pubTimestamp":1760546842,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日00时47分，Immuron Limited股票出现异动，股价急速上涨6.10%。截至发稿，该股报2.18美元/股，成交量5.9977万股，换手率0.89%，振幅5.61%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.88%。Immuron Limited公司简介：Immuron Ltd 是一家商业化和临床阶段的生物制药公司，拥有专有技术平台，专注于多克隆抗体，以解决尚未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016004722a461ba05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016004722a461ba05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2572522064","title":"Immuron Limited盘中异动 股价大涨6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572522064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572522064?lang=zh_cn&edition=full","pubTime":"2025-10-02 21:31","pubTimestamp":1759411911,"startTime":"0","endTime":"0","summary":"北京时间2025年10月02日21时31分，Immuron Limited股票出现波动，股价大幅上涨6.57%。截至发稿，该股报2.04美元/股，成交量6.7575万股，换手率1.01%，振幅2.62%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.53%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002213151a6ab2dd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002213151a6ab2dd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2558574180","title":"Immuron Limited盘中异动 股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558574180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558574180?lang=zh_cn&edition=full","pubTime":"2025-08-09 04:00","pubTimestamp":1754683207,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日04时00分，Immuron Limited股票出现异动，股价急速上涨5.56%。截至发稿，该股报1.71美元/股，成交量2.8346万股，换手率0.49%，振幅4.94%。Immuron Limited股票所在的生物技术行业中，整体跌幅为1.08%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809040007973c79ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809040007973c79ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2555703960","title":"Immuron Limited盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555703960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555703960?lang=zh_cn&edition=full","pubTime":"2025-07-29 00:40","pubTimestamp":1753720831,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日00时40分，Immuron Limited股票出现波动，股价急速跳水5.23%。截至发稿，该股报1.63美元/股，成交量9.0736万股，换手率1.58%，振幅4.94%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.15%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290040319723917a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290040319723917a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2552320487","title":"Immuron Limited盘中异动 急速跳水5.34%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552320487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552320487?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:32","pubTimestamp":1752759170,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时32分，Immuron Limited股票出现异动，股价急速下跌5.34%。截至发稿，该股报1.77美元/股，成交量1012.99万股，换手率176.83%，振幅6.42%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.13%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213250a4514015&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213250a4514015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2551184483","title":"Immuron Limited盘中异动 早盘股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551184483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551184483?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:31","pubTimestamp":1752499889,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时31分，Immuron Limited股票出现波动，股价急速上涨5.46%。截至发稿，该股报1.84美元/股，成交量1.0354万股，换手率0.18%，振幅3.16%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.17%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213129a44a1cea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213129a44a1cea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2549559475","title":"Immuron Limited盘中异动 股价大跌6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549559475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549559475?lang=zh_cn&edition=full","pubTime":"2025-07-08 00:10","pubTimestamp":1751904657,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日00时10分，Immuron Limited股票出现波动，股价大幅下挫6.08%。截至发稿，该股报1.67美元/股，成交量4642股，换手率0.08%，振幅2.25%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.54%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708001057a69b4f01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708001057a69b4f01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2548459011","title":"Immuron Limited盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548459011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548459011?lang=zh_cn&edition=full","pubTime":"2025-07-01 00:56","pubTimestamp":1751302594,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日00时56分，Immuron Limited股票出现异动，股价快速跳水5.41%。截至发稿，该股报1.75美元/股，成交量2.0344万股，换手率0.36%，振幅7.57%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.22%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701005634a7268f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701005634a7268f1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2545231524","title":"Immuron Limited盘中异动 大幅拉升5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545231524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545231524?lang=zh_cn&edition=full","pubTime":"2025-06-24 23:31","pubTimestamp":1750779073,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时31分，Immuron Limited股票出现异动，股价快速上涨5.74%。截至发稿，该股报1.94美元/股，成交量3.7497万股，换手率0.65%，振幅6.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.70%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624233113a71b7d05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624233113a71b7d05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2545772901","title":"Immuron Limited盘中异动 临近收盘股价大涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545772901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545772901?lang=zh_cn&edition=full","pubTime":"2025-06-21 03:38","pubTimestamp":1750448317,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日03时38分，Immuron Limited股票出现异动，股价快速上涨6.16%。截至发稿，该股报1.83美元/股，成交量3.4937万股，换手率0.61%，振幅3.05%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.61%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621033838a7151367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621033838a7151367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2544998461","title":"Immuron Limited盘中异动 早盘急速跳水5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544998461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544998461?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:41","pubTimestamp":1750167663,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日21时41分，Immuron Limited股票出现异动，股价快速下挫5.62%。截至发稿，该股报1.68美元/股，成交量1231股，换手率0.02%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.65%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617214103a70e7430&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617214103a70e7430&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2542310378","title":"Immuron Limited盘中异动 早盘股价大涨5.92%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542310378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542310378?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:32","pubTimestamp":1749562349,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时32分，Immuron Limited股票出现异动，股价急速拉升5.92%。截至发稿，该股报1.79美元/股，成交量1226股，换手率0.02%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.40%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213229a702391e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213229a702391e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2541863512","title":"Immuron Limited盘中异动 急速拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541863512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541863512?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:30","pubTimestamp":1749216645,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时30分，Immuron Limited股票出现异动，股价快速拉升5.88%。截至发稿，该股报1.80美元/股，成交量320股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.00%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506062130459774709b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506062130459774709b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2518222374","title":"Immuron Limited盘中异动 急速上涨12.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222374?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613497,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Immuron Limited股票出现波动，股价大幅上涨12.99%。截至发稿，该股报1.99美元/股，成交量416股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.59%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213137a26a247f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213137a26a247f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2517941563","title":"Immuron Limited盘中异动 早盘快速上涨13.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517941563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517941563?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:17","pubTimestamp":1741191475,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时17分，Immuron Limited股票出现异动，股价快速拉升13.32%。截至发稿，该股报1.99美元/股，成交量159股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.22%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306001756989d5ed8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306001756989d5ed8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2516658650","title":"Immuron Limited盘中异动 快速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658650?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:38","pubTimestamp":1741030707,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时38分，Immuron Limited股票出现波动，股价快速下跌5.26%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.61%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033827a25d950f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033827a25d950f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2514492370","title":"Immuron Limited盘中异动 股价大涨6.65%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514492370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514492370?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:50","pubTimestamp":1740516642,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时50分，Immuron Limited股票出现波动，股价大幅上涨6.65%。截至发稿，该股报1.98美元/股，成交量786股，换手率0.01%，振幅3.50%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.13%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045042abdcd48c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045042abdcd48c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2513299102","title":"Immuron Limited盘中异动 早盘股价大涨7.60%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513299102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513299102?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:08","pubTimestamp":1740150481,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时08分，Immuron Limited股票出现波动，股价急速上涨7.60%。截至发稿，该股报2.03美元/股，成交量509股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.06%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230801abd7b804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230801abd7b804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2509375922","title":"Immuron Limited盘中异动 大幅跳水5.32%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509375922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509375922?lang=zh_cn&edition=full","pubTime":"2025-02-06 02:18","pubTimestamp":1738779481,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日02时18分，Immuron Limited股票出现异动，股价急速跳水5.32%。截至发稿，该股报1.99美元/股，成交量359股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为2.10%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206021801a23aab67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206021801a23aab67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139","KTTA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immuron.com","stockEarnings":[{"period":"1week","weight":-0.0824},{"period":"1month","weight":-0.3882},{"period":"3month","weight":-0.5074},{"period":"6month","weight":-0.4913},{"period":"1year","weight":-0.5308},{"period":"ytd","weight":-0.4494}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immuron Limited于1994年根据澳大利亚法律成立。该公司是一家商业和临床阶段的生物制药公司，拥有一个专利技术平台，专注于开发和商业化一类新型的特异性靶向多克隆抗体，公司相信这种抗体能够解决严重的未满足医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.232349},{"month":2,"riseRate":0.125,"avgChangeRate":-0.076005},{"month":3,"riseRate":0.375,"avgChangeRate":0.023659},{"month":4,"riseRate":0.375,"avgChangeRate":0.002971},{"month":5,"riseRate":0.125,"avgChangeRate":-0.099969},{"month":6,"riseRate":0.428571,"avgChangeRate":0.327208},{"month":7,"riseRate":0.5,"avgChangeRate":0.019767},{"month":8,"riseRate":0.625,"avgChangeRate":-0.000199},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.058783},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.085183},{"month":11,"riseRate":0.444444,"avgChangeRate":0.02204},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.132716}],"exchange":"NASDAQ","name":"Immuron Ltd","nameEN":"Immuron Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immuron Ltd,IMRN,Immuron Ltd股票,Immuron Ltd股票老虎,Immuron Ltd股票老虎国际,Immuron Ltd行情,Immuron Ltd股票行情,Immuron Ltd股价,Immuron Ltd股市,Immuron Ltd股票价格,Immuron Ltd股票交易,Immuron Ltd股票购买,Immuron Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}